Mark Cuban Cost Plus Manufacturing and Compounding, LLC
FDA 503B outsourcing facility
Dallas, Texas
Key Takeaways
- FDA-registered 503B outsourcing facility since 2022
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: January 28, 2026
- FDA action: FMD-145 Issued 6/5/2025
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- November 2, 2022
- Most recent registration
- December 14, 2024
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- January 28, 2026
The FDA last inspected Mark Cuban Cost Plus Manufacturing and Compounding, LLC on January 28, 2026. Investigators issued a Form FDA 483 listing inspectional observations at that visit. FDA action on record: FMD-145 Issued 6/5/2025.
What this facility compounds
Mark Cuban Cost Plus Manufacturing and Compounding, LLC reports compounding 5 distinct active ingredients to the FDA Outsourcing Facility Product Report (most recent reporting periods).
Tracked on PeptideGrids: Oxytocin.
- Epinephrine
- Miglustat
- Norepinephrine Bitartrate
- Oxytocin
- Phenylephrine Hydrochloride
Location
320 S Walton St, Dallas, TX 75226
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Alexander Oshmyansky, 303-907-8003. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Mark Cuban Cost Plus Manufacturing and Compounding, LLC with the Texas State Board of Pharmacy.
503B facilities in Texas
Texas has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Texas.
Frequently asked questions
Is Mark Cuban Cost Plus Manufacturing and Compounding, LLC registered with the FDA?
Yes. Mark Cuban Cost Plus Manufacturing and Compounding, LLC is a registered 503B outsourcing facility, first registered with the FDA on November 2, 2022 and most recently registered on December 14, 2024.
Has Mark Cuban Cost Plus Manufacturing and Compounding, LLC been inspected by the FDA?
The FDA last inspected Mark Cuban Cost Plus Manufacturing and Compounding, LLC on January 28, 2026. A Form FDA 483 was issued. FDA action on record: FMD-145 Issued 6/5/2025.
Has Mark Cuban Cost Plus Manufacturing and Compounding, LLC had any FDA drug recalls?
No FDA drug recalls are matched to Mark Cuban Cost Plus Manufacturing and Compounding, LLC in the openFDA enforcement database.
What does Mark Cuban Cost Plus Manufacturing and Compounding, LLC compound?
Mark Cuban Cost Plus Manufacturing and Compounding, LLC reports compounding 5 active ingredients to the FDA, including Oxytocin.
Where is Mark Cuban Cost Plus Manufacturing and Compounding, LLC located?
Mark Cuban Cost Plus Manufacturing and Compounding, LLC is located in Dallas, Texas (320 S Walton St).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Mark Cuban Cost Plus Manufacturing and Compounding, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.